09.10.2025 • News
Harke Pharma Acquires Groundbreaking Memory Complex
Harke Pharma has completed the acquisition of a highly acclaimed nutraceutical Memory Complex originally developed by Green Bioactives, UK.
Pharma
Pharma 4.0 — the Key Enabler for Successful Digital Transformation in Pharma – part 2
Part 2: Digital transformation - 10 Years after the Start of Pharma 4.0
Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0
01.10.2025 • News
Symeres Appoints Gabriella Gentile as Chief Operating Officer
Symeres has appointed Gabriella Gentile as Chief Operating Officer to lead global operations and drive transatlantic growth, leveraging her extensive experience in the pharmaceutical and biotech sectors.
30.09.2025 • News
AbbVie Breaks Ground on US API Manufacturing Facility
New state-of-the-art active pharmaceutical ingredient (API) facility in North Chicago will manufacture immunology, oncology, and neuroscience medicines.
Pharma Strategies for Stability
October 15, 2025 | Join us for a dynamic virtual event where science meets strategy.
29.09.2025 • News • Bioprocessing
Siegfried Opens cGMP Viral Vectors Manufacturing Facility
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Lilly to Build $6.5 Billion US Pharmaceutical Plant
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.
Pfizer Agrees to Take Over Metsera for $4.9 Billion
Pfizer to acquire Metsera, a New York, NY-based clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.
Prange Pharma Acquires Site in Italy from MSD
Prange Pharma is taking over a production site from MSD Animal Health in Aprilia, Italy. A new center for contract manufacturing in the field of animal health products is to be established there.
Roche to Acquire 89Bio in $3.5 Billion Deal
Acquisition supports Roche’s strategy as it enhances the company’s portfolio in cardiovascular, renal, and metabolic diseases (CVRM) and offers optionality for future combination development.
GSK to Invest $30 Billion in US R&D and Manufacturing
Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.
Performance Improvement in Pharmaceuticals Operations
The pharmaceutical industry has faced significant margin pressures due to rising energy costs, inflation, and geopolitical disruptions.
Stability in Motion
Amid global uncertainty, Bayer Pharma, led by Stefan Oelrich, pursues strategic transformation to boost resilience, drive innovation, and secure sustainable growth in a changing healthcare landscape.
• 17.09.2025 • News • Bioprocessing
Strategic Perspectives on Life Sciences Industry Transformation
Asahi Kasei Life Science emerges as a new growth driver, uniting bioprocess solutions, CRO, and CDMO services to shape the future of healthcare under President Ken Shinomiya’s leadership.
LGC Opens $100 Million Pharma Synthesis Center in Canada
LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada.
11.09.2025 • News
Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Smart Capacity Planning for Pharma & Biotech Company
How pharma & biotech company transformed warehouse capacity planning for strategic growth
10.09.2025 • News
Symeres Acquires DGr Pharma
CRDMO Symeres has acquired DGr Pharma, expanding its capabilities with DGr Pharma’s regulatory and consultancy expertise to provide more comprehensive drug development services.
Gilead Breaks Ground on New US Manufacturing Hub
New Bay Area building marks significant progress as part of Gilead's $32 billion US investment.
Genentech and Roche Break Ground on US Manufacturing Facility
The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D
AbbVie to Acquire Gilgamesh Pharmaceutical’s Psychedelic Drug for $1.2B
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD).
AstraZeneca to Invest $50 Billion in US Manufacturing
AstraZeneca recently announced $50 billion of investment in the US by 2030. This investment is expected to create tens of thousands of new, highly skilled jobs nationwide.
Pharma Service Provider Vetter Establishes New Site in Chicago
Vetter broke ground for the start of construction of its new clinical site in Des Plaines, Illinois, US on June 26.
IMCD Acquires Indian Pharma Supplier Trichem
IMCD, a global partner for the distribution and formulation of speciality chemicals and ingredients, has acquired Trichem, an Indian pharmaceutical supplier.
Mabion Launches €500,000 Oncology Services Contest
Mabion, a biotech-focused CDMO offering end-to-end services, has announced the launch of a €500,000 oncology services contest at BIO International Convention 2025.
17.06.2025 • News • Bioprocessing
BASF Opens New GMP Center in Michigan, US
BASF has opened a new Good Manufacturing Practice (GMP) Solution Center in Wyandotte, Michigan, to support the supply of bioprocessing ingredients and excipients for the biopharma and pharmaceutical industries.
Brenntag Specialties Acquires Mcepharma
Brenntag recently announced the acquisition of Mcepharma to strengthen Brenntag’s capabilities across the entire pharmaceutical and biopharmaceutical value chain.
Sanofi to Acquire Vigil Neuroscience
Sanofi to acquire Vigil Neuroscience, a clinical-stage biotech focused on therapies for neurodegenerative diseases.
23.05.2025 • News
Siegfried Expands Production Capacity in El Masnou
Siegfried announced a further expansion of its ophthalmic drug manufacturing site in El Masnou near Barcelona, Spain.
Pharma Outlook 2025
The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.
14.05.2025 • Topics • Innovation
Motivation, Innovation, and the Power of Collaboration
Leading the Way in Pharmaceutical Manufacturing by Fostering an Agile Mindset and an Inclusive Culture.
“Access to Talent is a Crucial Factor”
In an interview with CHEManager, Edgardo Hernandez, President of Lilly Manufacturing, explains the strategy behind the ambitious investment project.
Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports
Thermal hoods, boxes, cooling elements, data loggers: Ecocool supplies suitable equipment for GDP-compliant transportation of temperature-sensitive pharmaceuticals.
Intelligent Engineering for Optimized Pharma Manufacturing
The Covid pandemic and its repercussions have changed the pharmaceutical industry and the healthcare markets. Richard Stedman, the CEO of ACG Engineering, discusses the lessons learned from the global supply chain disruptions and how innovative equipment helps pharma manufacturers overcome the challenges.
UBM Live
Mabion
Pfizer, Inc.
Roche Group
Gilead Sciences, Inc.
Multivac Sepp Haggenmüller SE & Co. KG
Bayer AG - Pharmaceuticals Communications & Health Policy
Vetter Pharma International GmbH
Packaging Coordinators, Inc.
Lonza AG
EMG The European Marketing Group BV
GlaxoSmithKline (GSK) plc
Farmindustria
PolarixPartner GmbH
Novo Nordisk A/S
F. Hoffmann-La Roche Ltd
AmbioPharm, Inc.
Avantor
EvaluatePharma
ISPE D/A/CH e.V.
Blue Sphere Health Ltd.
Lilly Deutschland GmbH
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
Siegfried
Ecocool GmbH
LGC Group
Accenture
Saltigo GmbH
CMS Advisors GmbH & Co. KG
Datamonitor Group
Miebach Consulting GmbH
PureTech Systems
Helsinn Chemicals SA
Camelot Management Consultants AG
VCI Verband Chem.- Ind. e.V
Mack Brooks Exhibition Ltd – Part of RX
GBI Research
Bayer AG
Evonik Nutrition & Care GmbH (Hanau)
Merck KGaA
Ashland
CHEManager International c/o Wiley-VCH GmbH
Ontario Int. Marketing Ct.
Arthur D. Little
ARC Advisory Group GmbH & Co KG
Eli Lilly and Company
AbbVie Inc.
gempex GmbH – THE GMP-EXPERT
Groupe Novasep
Symeres